ICH Q3B (R2) Impurities in new drug products

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberCPMP/ICH/2738/99
Effective from01/08/2003
KeywordsFinished product, impurities, reporting, control, qualification, specifications
DescriptionThis document provides guidance on the content and qualification of impurities in new drug products for registration applications. It applies to drug products produced from chemically synthesised new drug substances not previously registered in a region or Member State.

Related content

How helpful is this page?

Average rating:

 Based on 26 ratings

Add your rating:

See all ratings
5 ratings
5 ratings
5 ratings
5 ratings
6 ratings

Tell us more